Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor

被引:120
|
作者
Sotiropoulos, A
Moutoussamy, S
Renaudie, F
Clauss, N
Kayser, C
Gouilleux, F
Kelly, PA
Finidori, J
机构
[1] UNIV PARIS 05, INSERM U344, F-75730 PARIS 15, FRANCE
[2] HOP COCHIN, INSERM U363, F-75730 PARIS 14, FRANCE
关键词
D O I
10.1210/me.10.8.998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The GH receptor (GHR) is a member of the cytokine receptor superfamily; its signaling involves the activation of Janus tyrosine kinases (JAK2) and Stat (signal transducers and activators of transcription) transcription factors, Using truncated and tyrosine mutants of the receptor, we show that different receptor domains are essential for the activation of Stat3 and State. GH-dependent phosphorylation of JAK2, Stat3, and State, as well as transactivation studies with reporter genes containing Stat3 and State DNA-binding elements, was performed in cells expressing the various GHR mutants. The membrane-proximal region of the receptor necessary for JAK2 activation is sufficient for Stat3 activation. In contrast, C-terminal tyrosine residues of GHR are absolutely required for State activation. The same residues are also involved in the regulation of JAK2 dephosphorylation, possibly through the activation of a phosphatase. Using in vitro experiments with glutathione-S-transferase-fusion proteins, we demonstrate that the SH2 domain of Stat5 binds to the carboxy-terminal tyrosine-phosphorylated residues of GHR. Our results show that a cytokine receptor can mediate differently the activation of distinct Stat proteins that could be involved in cytokine-specific effects.
引用
收藏
页码:998 / 1009
页数:12
相关论文
共 50 条
  • [1] STAT3 and STAT5 Activation in Solid Cancers
    Igelmann, Sebastian
    Neubauer, Heidi A.
    Ferbeyre, Gerardo
    [J]. CANCERS, 2019, 11 (10)
  • [2] Distinct Role of STAT3 and STAT5 Factors in MDS and AML
    Fasouli, Eirini Sofia
    Giavi, Konstantina
    Makri, Charikleia
    Bystrykh, Leonid
    Bouchla, Anthi
    Athanasiadis, Emmanouil
    Vatsellas, Giannis
    Pappa, Vasiliki
    Katsantoni, Eleni
    [J]. BLOOD, 2023, 142
  • [3] STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and STAT3/STAT5 Disease Variants Modulate These Outcomes
    Hedl, Matija
    Sun, Rui
    Huang, Chen
    Abraham, Clara
    [J]. JOURNAL OF IMMUNOLOGY, 2019, 203 (12): : 3325 - 3338
  • [4] Growth hormone and lipopolysaccharide mutally modulate hepatic Stat3 and Stat5 in hypophysectomized rats
    Berry, SA
    Bergad, PL
    Schwarzenberg, SJ
    Humbert, JT
    Towle, HC
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 124A - 124A
  • [5] Distinct mechanisms of STAT phosphorylation via the interferon-α/β receptor -: Selective inhibition of STAT3 and STAT5 by piceatannol
    Su, L
    David, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (17) : 12661 - 12666
  • [6] Targeting STAT3 and STAT5 in Cancer
    de Araujo, Elvin D.
    Keseru, Gyorgy M.
    Gunning, Patrick T.
    Moriggl, Richard
    [J]. CANCERS, 2020, 12 (08)
  • [7] Simultaneous detection of STAT1, STAT3, and STAT5 activation in response to interferons
    Brodey, Mary M.
    Zheng, Wei
    Wang, Jimin
    Reagan, Kevin
    [J]. CYTOKINE, 2008, 43 (03) : 241 - 241
  • [8] THROMBOPOIETIN (TPO) INDUCES TYROSINE PHOSPHORYLATION AND ACTIVATION OF STAT5 AND STAT3
    BACON, CM
    TORTOLANI, PJ
    SHIMOSAKA, A
    REES, RC
    LONGO, DL
    OSHEA, JJ
    [J]. FEBS LETTERS, 1995, 370 (1-2) : 63 - 68
  • [9] Growth hormone receptor contributes to the activation of STAT5 in the hypothalamus of pregnant mice
    Wasinski, Frederick
    Teixeira, Pryscila D. S.
    List, Edward O.
    Kopchick, John J.
    Donato Jr, Jose
    [J]. NEUROSCIENCE LETTERS, 2022, 770
  • [10] Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer
    Walker, Sarah R.
    Xiang, Michael
    Frank, David A.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 382 (01) : 616 - 621